Iliac stent market seen reaching $1.5 billion by 2030

The iliac stent market is projected to grow from $1.09 billion in 2025 to $1.17 billion in 2026, then reach $1.5 billion by 2030, according to a new industry report. The forecast points to rising peripheral artery disease cases, broader use of minimally invasive procedures and faster growth in Asia-Pacific.

Why it matters: - The iliac stent market is tied directly to treatment for peripheral artery disease and other blocked-artery conditions. - Faster adoption of minimally invasive vascular procedures could expand access to care and shift more treatment into outpatient settings. - The market’s growth reflects rising demand for devices used to restore blood flow and reduce complications from arterial narrowing.

What happened: - The Business Research Company released a report titled The Business Research Company's Iliac Stent Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035. - The report estimates the iliac stent market will rise from $1.09 billion in 2025 to $1.17 billion in 2026, a 7.2% compound annual growth rate. - The market is forecast to reach $1.5 billion by 2030, growing at a 6.4% CAGR over the forecast period. - North America held the largest share of the global iliac stent market in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report was published in London on Aug. 11, 2026. - Download a free sample of the report. - View the full report.

The details: - Iliac stents are designed to treat atherosclerosis in the iliac arteries in the pelvic area. - The devices are inserted through minimally invasive procedures such as angioplasty to widen narrowed or blocked arteries. - The treatment improves blood flow and reduces symptoms linked to artery obstruction. - Growth in 2025 and 2026 is linked to rising peripheral artery disease, an aging population, greater acceptance of endovascular procedures, expansion of hospital vascular care services and better diagnosis of iliac artery lesions. - Expected growth through 2030 is driven by demand for minimally invasive treatment, more lifestyle-related vascular disease, broader access to interventional cardiology, higher healthcare spending in developing countries and earlier vascular intervention. - Key forecast-period trends include greater use of minimally invasive peripheral interventions, preference for self-expandable iliac stents, and more drug-eluting and covered stents for complex arterial lesions. - The report also points to a move toward outpatient and day-care endovascular procedures. - Use cases are expanding for severe and calcified lesions. - The report adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables.

Between the lines: - The report points to a market moving from basic vessel repair toward more specialized device selection for complex disease. - Rising PAD prevalence is the clearest demand signal, and it supports both device volume and procedure growth. - The regional split suggests mature demand in North America and faster expansion where healthcare investment and technology access are still improving. - The added analytics tools signal that buyers and investors may be looking for more granular market sizing and competitive comparison.

What's next: - The report expects continued adoption of minimally invasive vascular care to support steady market growth through 2030. - Increasing PAD cases, especially in aging and high-risk populations, are likely to keep demand elevated. - Device makers are likely to focus on self-expandable, drug-eluting and covered stent segments as treatment complexity rises. - The broader market opportunity is expected to deepen as more procedures move to outpatient settings and more regions expand interventional capability.